Glaxosmithkline | GSK - Resultado Líquido

Preço das Ações
53.85
Mudança Diária
-5.27 -8.91%
Mensal
-9.13%
Anual
39.00%
Q1 Previsão
52.69




Resultado Líquido Alterar Data
AbbVie USD 1.82B 1.63B 2025-12
Amgen USD 1.33B 1.88B 2025-12
AstraZeneca USD 2.33B 207M 2025-12
Aurora Cannabis CAD 1.82M 53.29M 2025-12
Bausch Health Companies USD -112M 291M 2025-12
Bristol-Myers Squibb USD 1.09B 1.11B 2025-12
Canopy Growth CAD -62.63M 60.99M 2025-12
Corcept Therapeutics USD 24.29M 4.62M 2025-12
Drreddys Laboratories INR 12.1B 2.08B 2025-12
Eli Lilly USD 6.64B 1.05B 2025-12
GlaxoSmithKline GBP 636M 1.38B 2025-12
Glaxosmithkline GBP 846.06M 1.87B 2025-12
J&J USD 5.12B 36M 2025-12
Merck USD 2.96B 2.82B 2025-12
Novartis USD 2.41B 1.52B 2025-12
Pacira USD 1.64M 3.8M 2025-12
Perrigo USD -1.42B 1.43B 2025-12
Pfizer USD -1.65B 5.19B 2025-12
Phibro Animal Health USD 27.46M 932K 2025-12
Prestige Brands USD 46.7M 22.44M 2025-12
Roche Holding CHF 5.47B 1.76B 2025-12
Sanofi EUR -801M 3.6B 2025-12
Supernus Pharmaceuticals USD -45.12M 67.62M 2025-09
Takeda JPY 103.64B 115.44B 2025-12
Teva Pharmaceutical Industries USD 480M 47M 2025-12
Zoetis USD 603M 118M 2025-12